A citation-based method for searching scientific literature

Gabriela Bravo Montenegro, Saira Farid, Stephen V Liu. J Surg Oncol 2021
Times Cited: 2







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Targeted sequencing reveals clonal genetic changes in the progression of early lung neoplasms and paired circulating DNA.
Evgeny Izumchenko, Xiaofei Chang, Mariana Brait, Elana Fertig, Luciane T Kagohara, Atul Bedi, Luigi Marchionni, Nishant Agrawal, Rajani Ravi, Sian Jones,[...]. Nat Commun 2015
95
50

Sodium-glucose transporter 2 is a diagnostic and therapeutic target for early-stage lung adenocarcinoma.
Claudio R Scafoglio, Brendon Villegas, Gihad Abdelhady, Sean T Bailey, Jie Liu, Aditya S Shirali, W Dean Wallace, Clara E Magyar, Tristan R Grogan, David Elashoff,[...]. Sci Transl Med 2018
49
50

Lung Cancer Subtypes Generate Unique Immune Responses.
Stephanie E Busch, Mark L Hanke, Julia Kargl, Heather E Metz, David MacPherson, A McGarry Houghton. J Immunol 2016
75
50


Immune reprogramming via PD-1 inhibition enhances early-stage lung cancer survival.
Geoffrey J Markowitz, Lauren S Havel, Michael Jp Crowley, Yi Ban, Sharrell B Lee, Jennifer S Thalappillil, Navneet Narula, Bhavneet Bhinder, Olivier Elemento, Stephen Tc Wong,[...]. JCI Insight 2018
23
50

Neoadjuvant and Adjuvant Immunotherapy: Opening New Horizons for Patients With Early-Stage Non-small Cell Lung Cancer.
Rilan Bai, Lingyu Li, Xiao Chen, Naifei Chen, Wei Song, Jiuwei Cui. Front Oncol 2020
18
50

Immunostimulation with chemotherapy in the era of immune checkpoint inhibitors.
Lorenzo Galluzzi, Juliette Humeau, Aitziber Buqué, Laurence Zitvogel, Guido Kroemer. Nat Rev Clin Oncol 2020
110
50

Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer.
Naiyer A Rizvi, Matthew D Hellmann, Alexandra Snyder, Pia Kvistborg, Vladimir Makarov, Jonathan J Havel, William Lee, Jianda Yuan, Phillip Wong, Teresa S Ho,[...]. Science 2015
50

Neutrophils and Snail Orchestrate the Establishment of a Pro-tumor Microenvironment in Lung Cancer.
Julien Faget, Svenja Groeneveld, Gael Boivin, Martial Sankar, Nadine Zangger, Miguel Garcia, Nicolas Guex, Inti Zlobec, Loïc Steiner, Alessandra Piersigilli,[...]. Cell Rep 2017
76
50

Pembrolizumab for the treatment of non-small-cell lung cancer.
Edward B Garon, Naiyer A Rizvi, Rina Hui, Natasha Leighl, Ani S Balmanoukian, Joseph Paul Eder, Amita Patnaik, Charu Aggarwal, Matthew Gubens, Leora Horn,[...]. N Engl J Med 2015
50

Neoadjuvant PD-1 Blockade in Resectable Lung Cancer.
Patrick M Forde, Jamie E Chaft, Kellie N Smith, Valsamo Anagnostou, Tricia R Cottrell, Matthew D Hellmann, Marianna Zahurak, Stephen C Yang, David R Jones, Stephen Broderick,[...]. N Engl J Med 2018
733
50

BET Bromodomain Inhibition Cooperates with PD-1 Blockade to Facilitate Antitumor Response in Kras-Mutant Non-Small Cell Lung Cancer.
Dennis O Adeegbe, Shengwu Liu, Maureen M Hattersley, Michaela Bowden, Chensheng W Zhou, Shuai Li, Raven Vlahos, Michael Grondine, Igor Dolgalev, Elena V Ivanova,[...]. Cancer Immunol Res 2018
39
50

Novel Kras-mutant murine models of non-small cell lung cancer possessing co-occurring oncogenic mutations and increased tumor mutational burden.
Ramin Salehi-Rad, Rui Li, Linh M Tran, Raymond J Lim, Jensen Abascal, Milica Momcilovic, Stacy J Park, Stephanie L Ong, Maryam Shabihkhani, Zi Ling Huang,[...]. Cancer Immunol Immunother 2021
4
50

Immunotherapy in non-small cell lung cancer: Update and new insights.
Xabier Mielgo-Rubio, Eider Azkona Uribelarrea, Laura Quintanta Cortés, María Sereno Moyano. J Clin Transl Res 2021
2
50

Functional expression of sodium-glucose transporters in cancer.
Claudio Scafoglio, Bruce A Hirayama, Vladimir Kepe, Jie Liu, Chiara Ghezzi, Nagichettiar Satyamurthy, Neda A Moatamed, Jiaoti Huang, Hermann Koepsell, Jorge R Barrio,[...]. Proc Natl Acad Sci U S A 2015
115
50

Activation of the Ki-ras protooncogene in spontaneously occurring and chemically induced lung tumors of the strain A mouse.
M You, U Candrian, R R Maronpot, G D Stoner, M W Anderson. Proc Natl Acad Sci U S A 1989
358
50

Immune checkpoint-inhibitors and chemoradiation in stage III unresectable non-small cell lung cancer.
Barbara Melosky, Rosalyn Juergens, Deanna McLeod, Natasha Leighl, Anthony Brade, Paul B Card, Quincy Chu. Lung Cancer 2019
20
50

The mutational landscapes of genetic and chemical models of Kras-driven lung cancer.
Peter M K Westcott, Kyle D Halliwill, Minh D To, Mamunur Rashid, Alistair G Rust, Thomas M Keane, Reyno Delrosario, Kuang-Yu Jen, Kay E Gurley, Christopher J Kemp,[...]. Nature 2015
200
50

TP53, STK11, and EGFR Mutations Predict Tumor Immune Profile and the Response to Anti-PD-1 in Lung Adenocarcinoma.
Jérôme Biton, Audrey Mansuet-Lupo, Nicolas Pécuchet, Marco Alifano, Hanane Ouakrim, Jennifer Arrondeau, Pascaline Boudou-Rouquette, François Goldwasser, Karen Leroy, Jeremy Goc,[...]. Clin Cancer Res 2018
129
50

QuPath: Open source software for digital pathology image analysis.
Peter Bankhead, Maurice B Loughrey, José A Fernández, Yvonne Dombrowski, Darragh G McArt, Philip D Dunne, Stephen McQuaid, Ronan T Gray, Liam J Murray, Helen G Coleman,[...]. Sci Rep 2017
50

The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of non-small cell lung cancer (NSCLC).
Julie R Brahmer, Ramaswamy Govindan, Robert A Anders, Scott J Antonia, Sarah Sagorsky, Marianne J Davies, Steven M Dubinett, Andrea Ferris, Leena Gandhi, Edward B Garon,[...]. J Immunother Cancer 2018
99
50

STK11/LKB1 Mutations and PD-1 Inhibitor Resistance in KRAS-Mutant Lung Adenocarcinoma.
Ferdinandos Skoulidis, Michael E Goldberg, Danielle M Greenawalt, Matthew D Hellmann, Mark M Awad, Justin F Gainor, Alexa B Schrock, Ryan J Hartmaier, Sally E Trabucco, Laurie Gay,[...]. Cancer Discov 2018
552
50

Somatic mutations affect key pathways in lung adenocarcinoma.
Li Ding, Gad Getz, David A Wheeler, Elaine R Mardis, Michael D McLellan, Kristian Cibulskis, Carrie Sougnez, Heidi Greulich, Donna M Muzny, Margaret B Morgan,[...]. Nature 2008
50

KEAP1-driven co-mutations in lung adenocarcinoma unresponsive to immunotherapy despite high tumor mutational burden.
D Marinelli, M Mazzotta, S Scalera, I Terrenato, F Sperati, L D'Ambrosio, M Pallocca, G Corleone, E Krasniqi, L Pizzuti,[...]. Ann Oncol 2020
42
50

Computational Pipeline for the PGV-001 Neoantigen Vaccine Trial.
Alex Rubinsteyn, Julia Kodysh, Isaac Hodes, Sebastien Mondet, Bulent Arman Aksoy, John P Finnigan, Nina Bhardwaj, Jeffrey Hammerbacher. Front Immunol 2018
22
50

Of mice and not men: differences between mouse and human immunology.
Javier Mestas, Christopher C W Hughes. J Immunol 2004
50

Systemic clinical tumor regressions and potentiation of PD1 blockade with in situ vaccination.
Linda Hammerich, Thomas U Marron, Ranjan Upadhyay, Judit Svensson-Arvelund, Maxime Dhainaut, Shafinaz Hussein, Yougen Zhan, Dana Ostrowski, Michael Yellin, Henry Marsh,[...]. Nat Med 2019
153
50

Antitumor activity and long-term fate of chimeric antigen receptor-positive T cells in patients with neuroblastoma.
Chrystal U Louis, Barbara Savoldo, Gianpietro Dotti, Martin Pule, Eric Yvon, G Doug Myers, Claudia Rossig, Heidi V Russell, Oumar Diouf, Enli Liu,[...]. Blood 2011
695
50

Humanized hemato-lymphoid system mice.
Alexandre P A Theocharides, Anthony Rongvaux, Kristin Fritsch, Richard A Flavell, Markus G Manz. Haematologica 2016
103
50

Humanized mice mount specific adaptive and innate immune responses to EBV and TSST-1.
Michael W Melkus, Jacob D Estes, Angela Padgett-Thomas, Joel Gatlin, Paul W Denton, Florence A Othieno, Anja K Wege, Ashley T Haase, J Victor Garcia. Nat Med 2006
460
50


Humanized mice in studying efficacy and mechanisms of PD-1-targeted cancer immunotherapy.
Minan Wang, Li-Chin Yao, Mingshan Cheng, Danying Cai, Jan Martinek, Chong-Xian Pan, Wei Shi, Ai-Hong Ma, Ralph W De Vere White, Susan Airhart,[...]. FASEB J 2018
139
50

Humanized mice for immune system investigation: progress, promise and challenges.
Leonard D Shultz, Michael A Brehm, J Victor Garcia-Martinez, Dale L Greiner. Nat Rev Immunol 2012
569
50


Antibody-drug conjugates--an emerging class of cancer treatment.
Nikolaos Diamantis, Udai Banerji. Br J Cancer 2016
247
50

Hallmarks of cancer: the next generation.
Douglas Hanahan, Robert A Weinberg. Cell 2011
50

Studies of lymphocyte reconstitution in a humanized mouse model reveal a requirement of T cells for human B cell maturation.
Julie Lang, Margot Kelly, Brian M Freed, Martin D McCarter, Ross M Kedl, Raul M Torres, Roberta Pelanda. J Immunol 2013
75
50

Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice.
L D Shultz, P A Schweitzer, S W Christianson, B Gott, I B Schweitzer, B Tennent, S McKenna, L Mobraaten, T V Rajan, D L Greiner. J Immunol 1995
845
50

Recent advances and discoveries in the mechanisms and functions of CAR T cells.
Rebecca C Larson, Marcela V Maus. Nat Rev Cancer 2021
44
50


Docetaxel gold complex nanoflowers: A chemo-biological evaluation for their use as nanotherapeutics.
Maroua Ben Haddada, Dania Movia, Adriele Prina-Mello, Jolanda Spadavecchia. Colloids Surf B Biointerfaces 2020
3
50



NOD/SCID/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells.
Mamoru Ito, Hidefumi Hiramatsu, Kimio Kobayashi, Kazutomo Suzue, Mariko Kawahata, Kyoji Hioki, Yoshito Ueyama, Yoshio Koyanagi, Kazuo Sugamura, Kohichiro Tsuji,[...]. Blood 2002
986
50

Molecular Engineering of Ultrasmall Silica Nanoparticle-Drug Conjugates as Lung Cancer Therapeutics.
Brian Madajewski, Feng Chen, Barney Yoo, Melik Z Turker, Kai Ma, Li Zhang, Pei-Ming Chen, Rupa Juthani, Virginia Aragon-Sanabria, Mithat Gonen,[...]. Clin Cancer Res 2020
3
50

Engineering a targeted delivery platform using Centyrins.
Shalom D Goldberg, Rosa M F Cardoso, Tricia Lin, Tracy Spinka-Doms, Donna Klein, Steven A Jacobs, Vadim Dudkin, Gary Gilliland, Karyn T O'Neil. Protein Eng Des Sel 2016
24
50


The analysis of the functions of human B and T cells in humanized NOD/shi-scid/gammac(null) (NOG) mice (hu-HSC NOG mice).
Yohei Watanabe, Takeshi Takahashi, Akira Okajima, Miho Shiokawa, Naoto Ishii, Ikumi Katano, Ryoji Ito, Mamoru Ito, Masayoshi Minegishi, Naoko Minegishi,[...]. Int Immunol 2009
144
50

Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy.
Christine E Brown, Darya Alizadeh, Renate Starr, Lihong Weng, Jamie R Wagner, Araceli Naranjo, Julie R Ostberg, M Suzette Blanchard, Julie Kilpatrick, Jennifer Simpson,[...]. N Engl J Med 2016
710
50



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.